11 Stocks that Paid Special Dividends in 2024
In this article, we discuss 11 stocks that paid special dividends in 2024.
Graphite Corp (GRPH)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.05 | 20,000,000 | $1,074,000.00 | 30,000,000 | 2014-10-08 | Filing | |
| $0.05 | 10,000,000 | $537,000.00 | 30,000,000 | 2014-08-09 | Filing | |
| $0.05 | 20,000,000 | $1,074,000.00 | 30,000,000 | 2014-10-08 | Filing | |
| $0.05 | 10,000,000 | $537,000.00 | 30,000,000 | 2014-08-09 | Filing | |
| $1,074,000.00 | 20,000,000 | $21,480,000,000,000.00 | 30,000,000 | 2014-10-08 | Filing |
News See All
12 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 12 gene editing stocks with the best long-term potential.
11 Most Promising Gene Editing Stocks According to Analysts
In this article, we will take a look at the 11 most promising gene editing stocks according to analysts.
5 Best Gene Editing Stocks To Buy
Graphite Bio, Inc. (NASDAQ:GRPH) is a clinical-stage gene editing company based in San Francisco, California. It develops therapies for life-threatening diseases in the United States.
Top 5 Stock Picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we discuss the top 5 stock picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
5 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we will discuss 5 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Billionaire Hedge Funds
